1,5-(Butylimino)-1,5 dideoxy,D-glucitol | |
---|---|
Trade Name | |
Orphan Indication | Fabry disease |
USA Market Approval | USA |
USA Designation Date | 1998-05-12 00:00:00 |
Sponsor | Oxford GlycoSciences;10, The Quadrant, Abington Science Park;United Kingdom |
Related Access Program